GPR137B
gene geneOn this page
Summary
GPR137B (G protein-coupled receptor 137B, HGNC:11862) is a protein-coding gene on chromosome 1q42.3, encoding Integral membrane protein GPR137B (O60478). Lysosomal integral membrane protein that regulates the localization and activity of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids.
Involved in positive regulation of TORC1 signaling; positive regulation of protein localization to lysosome; and regulation of autophagy. Located in lysosomal membrane.
Source: NCBI Gene 7107 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 61 total — 2 pathogenic
- MANE Select transcript:
NM_003272
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11862 |
| Approved symbol | GPR137B |
| Name | G protein-coupled receptor 137B |
| Location | 1q42.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000077585 |
| Ensembl biotype | protein_coding |
| OMIM | 604658 |
| Entrez | 7107 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 10 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000366591, ENST00000366592, ENST00000419162, ENST00000454895, ENST00000477559, ENST00000889782, ENST00000889783, ENST00000889784, ENST00000889785, ENST00000889786, ENST00000972103, ENST00000972104, ENST00000972105
RefSeq mRNA: 1 — MANE Select: NM_003272
NM_003272
CCDS: CCDS1609
Canonical transcript exons
ENST00000366592 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000961594 | 236168706 | 236168755 |
| ENSE00001022688 | 236208050 | 236208907 |
| ENSE00001442134 | 236142539 | 236143036 |
| ENSE00003465477 | 236205126 | 236205250 |
| ENSE00003577777 | 236178414 | 236178636 |
| ENSE00003694495 | 236183778 | 236183906 |
| ENSE00003741263 | 236179879 | 236180028 |
Expression profiles
Bgee: expression breadth ubiquitous, 283 present calls, max score 96.81.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 32.0933 / max 411.4252, expressed in 1723 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 9215 | 30.8420 | 1720 |
| 9214 | 1.2514 | 792 |
Top tissues by expression
294 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pigmented layer of retina | UBERON:0001782 | 96.81 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 96.01 | gold quality |
| medial globus pallidus | UBERON:0002477 | 95.55 | gold quality |
| oocyte | CL:0000023 | 95.50 | gold quality |
| corpus epididymis | UBERON:0004359 | 95.30 | gold quality |
| nephron tubule | UBERON:0001231 | 94.68 | gold quality |
| globus pallidus | UBERON:0001875 | 94.64 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 94.26 | gold quality |
| secondary oocyte | CL:0000655 | 94.05 | gold quality |
| nucleus accumbens | UBERON:0001882 | 93.64 | gold quality |
| caudate nucleus | UBERON:0001873 | 93.59 | gold quality |
| putamen | UBERON:0001874 | 93.27 | gold quality |
| tibial nerve | UBERON:0001323 | 92.86 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 92.67 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 92.62 | gold quality |
| spinal cord | UBERON:0002240 | 92.50 | gold quality |
| buccal mucosa cell | CL:0002336 | 92.48 | gold quality |
| heart right ventricle | UBERON:0002080 | 91.77 | gold quality |
| periodontal ligament | UBERON:0008266 | 91.76 | gold quality |
| ventricular zone | UBERON:0003053 | 91.73 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 91.71 | gold quality |
| olfactory bulb | UBERON:0002264 | 91.64 | gold quality |
| amygdala | UBERON:0001876 | 91.62 | gold quality |
| stromal cell of endometrium | CL:0002255 | 91.25 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 91.06 | gold quality |
| cranial nerve II | UBERON:0000941 | 90.84 | gold quality |
| substantia nigra | UBERON:0002038 | 90.78 | gold quality |
| adult organism | UBERON:0007023 | 90.54 | gold quality |
| caput epididymis | UBERON:0004358 | 90.48 | gold quality |
| midbrain | UBERON:0001891 | 90.37 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-135922 | yes | 20.03 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
92 targeting GPR137B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
Literature-anchored findings (GeneRIF, showing 1)
- PR137B-knockout cells exhibited defective autophagy and an expanded lysosome compartment, similar to Rag-knockout cells. Like zebrafish RagA mutants, GPR137B-mutant zebrafish had upregulated TFEB target gene expression and an expanded lysosome compartment in microglia. (PMID:31036939)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gpr137bb | ENSDARG00000077608 |
| danio_rerio | gpr137ba | ENSDARG00000078448 |
| mus_musculus | Gpr137b | ENSMUSG00000021306 |
| rattus_norvegicus | Gpr137b | ENSRNOG00000002480 |
Paralogs (2): GPR137 (ENSG00000173264), GPR137C (ENSG00000180998)
Protein
Protein identifiers
Integral membrane protein GPR137B — O60478 (reviewed: O60478)
Alternative names: Transmembrane 7 superfamily member 1 protein
All UniProt accessions (3): O60478, H0Y509, Q5TAF0
UniProt curated annotations — full annotation on UniProt →
Function. Lysosomal integral membrane protein that regulates the localization and activity of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids. Interacts with Rag GTPases and increases the lysosomial localization and activity of Rag GTPases and thereby regulates mTORC1 translocation and activity in lysosome. Involved in the regulation of lysosomal morphology and autophagy. Also acts as a negative regulator of osteoclast activity. Involved in interleukin-4-induced M2 macrophage polarization.
Subunit / interactions. Interaction with RRAGA; increases RRAGA recruitment to lysosomes. Interacts with MTOR; this interaction is amino acid sensitive.
Subcellular location. Lysosome membrane.
Tissue specificity. Expressed in kidney, heart, brain and placenta.
Similarity. Belongs to the GPR137 family.
RefSeq proteins (1): NP_003263* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029723 | GPR137 | Family |
UniProt features (23 total): topological domain 8, transmembrane region 7, glycosylation site 3, sequence conflict 3, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O60478-F1 | 69.47 | 0.26 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (3): 26, 263, 275
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 337 (showing top):
GOBP_MYELOID_CELL_DIFFERENTIATION, GOBP_REGULATION_OF_CELL_ACTIVATION, MULLIGHAN_NPM1_SIGNATURE_3_UP, GOBP_REGULATION_OF_AUTOPHAGY, GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT, FREAC2_01, GOBP_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION, KAAB_FAILED_HEART_ATRIUM_DN, GOCC_VACUOLAR_MEMBRANE, GOZGIT_ESR1_TARGETS_DN, GOBP_POSITIVE_REGULATION_OF_TOR_SIGNALING, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION, GOBP_REGULATION_OF_GTPASE_ACTIVITY, GOBP_REGULATION_OF_MACROPHAGE_ACTIVATION
GO Biological Process (8): autophagy (GO:0006914), regulation of autophagy (GO:0010506), regulation of macrophage activation (GO:0043030), regulation of GTPase activity (GO:0043087), negative regulation of osteoclast differentiation (GO:0045671), negative regulation of bone resorption (GO:0045779), positive regulation of protein localization to lysosome (GO:0150032), positive regulation of TORC1 signaling (GO:1904263)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): lysosomal membrane (GO:0005765), plasma membrane (GO:0005886), membrane (GO:0016020), lysosome (GO:0005764)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| catabolic process | 1 |
| transmembrane transport | 1 |
| process utilizing autophagic mechanism | 1 |
| autophagy | 1 |
| regulation of catabolic process | 1 |
| regulation of leukocyte activation | 1 |
| macrophage activation | 1 |
| GTPase activity | 1 |
| regulation of hydrolase activity | 1 |
| negative regulation of myeloid leukocyte differentiation | 1 |
| osteoclast differentiation | 1 |
| regulation of osteoclast differentiation | 1 |
| regulation of bone resorption | 1 |
| bone resorption | 1 |
| negative regulation of bone remodeling | 1 |
| protein localization to lysosome | 1 |
| regulation of protein localization to lysosome | 1 |
| positive regulation of protein localization | 1 |
| positive regulation of TOR signaling | 1 |
| TORC1 signaling | 1 |
| regulation of TORC1 signaling | 1 |
| binding | 1 |
| lysosome | 1 |
| lytic vacuole membrane | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
| lytic vacuole | 1 |
Protein interactions and networks
STRING
458 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GPR137B | GPR108 | Q9NPR9 | 552 |
| GPR137B | GPR107 | Q5VW38 | 520 |
| GPR137B | GPR155 | Q7Z3F1 | 483 |
| GPR137B | GPR152 | Q8TDT2 | 437 |
| GPR137B | TM7SF3 | Q9NS93 | 432 |
| GPR137B | GPR82 | Q96P67 | 413 |
| GPR137B | GPR143 | P51810 | 412 |
| GPR137B | CHST8 | Q9H2A9 | 395 |
| GPR137B | GPRC5C | Q9NQ84 | 390 |
| GPR137B | COPS5 | Q92905 | 380 |
| GPR137B | SLC26A9 | Q7LBE3 | 349 |
| GPR137B | PAQR9 | Q6ZVX9 | 346 |
| GPR137B | OPN3 | Q9H1Y3 | 344 |
| GPR137B | GPR153 | Q6NV75 | 338 |
| GPR137B | GPR171 | O14626 | 333 |
IntAct
20 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GPR137B | USP20 | psi-mi:“MI:0915”(physical association) | 0.600 |
| USP20 | GPR137B | psi-mi:“MI:0407”(direct interaction) | 0.600 |
| GPR137B | TRIM32 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPR137B | DOC2A | psi-mi:“MI:0914”(association) | 0.530 |
| USP33 | GPR137B | psi-mi:“MI:0915”(physical association) | 0.520 |
| GPR137B | GPR137B | psi-mi:“MI:0915”(physical association) | 0.400 |
| GPR137B | HIF1A | psi-mi:“MI:0915”(physical association) | 0.400 |
| APP | GPR137B | psi-mi:“MI:0915”(physical association) | 0.370 |
| GPR137B | SMC2 | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| TRIM32 | GPR137B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (21): NCAPD2 (Affinity Capture-MS), SMC2 (Affinity Capture-MS), ZYG11B (Affinity Capture-MS), NCAPH (Affinity Capture-MS), DOC2A (Affinity Capture-MS), NCAPG (Affinity Capture-MS), DOC2A (Affinity Capture-MS), NCAPD2 (Affinity Capture-MS), NCAPH (Affinity Capture-MS), NCAPG (Affinity Capture-MS), ZYG11B (Affinity Capture-MS), SMC2 (Affinity Capture-MS), GPR137B (Affinity Capture-RNA), GPR137B (Two-hybrid), TRIM32 (Two-hybrid)
ESM2 similar proteins: A2BGS3, A6NGA9, E7F594, O36364, O60478, O60883, O95800, O95838, P03208, P16849, P31389, P34590, P35367, P49219, Q03613, Q09351, Q09964, Q09965, Q14439, Q16950, Q16951, Q2KI97, Q3U3F9, Q5FVG1, Q5IXF8, Q5UAW9, Q60755, Q64017, Q66615, Q66H29, Q6P7G9, Q6SW98, Q6X632, Q7TSN5, Q7TSN6, Q80W35, Q80WT4, Q8BNQ3, Q8C206, Q8CIM5
Diamond homologs: E7F594, E9Q343, O60478, Q17QQ5, Q6DCW7, Q80ZU9, Q8BNQ3, Q8N3F9, Q96N19
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 625533 | GRCh37/hg19 1q42.3-43(chr1:234742890-239475761) | Pathogenic |
| 814181 | GRCh37/hg19 1q42.2-43(chr1:233843930-237971511)x1 | Pathogenic |
SpliceAI
1653 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:236143033:GCAG:G | donor_gain | 1.0000 |
| 1:236143034:CAGG:C | donor_loss | 1.0000 |
| 1:236143035:AGGT:A | donor_loss | 1.0000 |
| 1:236143036:GGT:G | donor_loss | 1.0000 |
| 1:236143037:GTGA:G | donor_loss | 1.0000 |
| 1:236143038:T:A | donor_loss | 1.0000 |
| 1:236179873:TTCCA:T | acceptor_loss | 1.0000 |
| 1:236179874:TCCAG:T | acceptor_loss | 1.0000 |
| 1:236179875:CCA:C | acceptor_loss | 1.0000 |
| 1:236179876:CA:C | acceptor_loss | 1.0000 |
| 1:236179877:A:AT | acceptor_loss | 1.0000 |
| 1:236179877:AG:A | acceptor_gain | 1.0000 |
| 1:236179878:GG:G | acceptor_gain | 1.0000 |
| 1:236183777:GGCA:G | acceptor_gain | 1.0000 |
| 1:236183903:CCTT:C | donor_gain | 1.0000 |
| 1:236183907:G:GG | donor_gain | 1.0000 |
| 1:236220826:TCTTA:T | donor_loss | 1.0000 |
| 1:236220827:CTTA:C | donor_loss | 1.0000 |
| 1:236220828:TTAC:T | donor_loss | 1.0000 |
| 1:236220829:TA:T | donor_loss | 1.0000 |
| 1:236220830:A:AG | donor_loss | 1.0000 |
| 1:236220862:T:TA | donor_gain | 1.0000 |
| 1:236220961:TGAGT:T | acceptor_gain | 1.0000 |
| 1:236220962:GAGT:G | acceptor_gain | 1.0000 |
| 1:236220964:GT:G | acceptor_gain | 1.0000 |
| 1:236220966:C:CC | acceptor_gain | 1.0000 |
| 1:236143032:CGCAG:C | donor_gain | 0.9900 |
| 1:236143033:GCAGG:G | donor_gain | 0.9900 |
| 1:236143037:G:GG | donor_gain | 0.9900 |
| 1:236168700:TTGCA:T | acceptor_loss | 0.9900 |
AlphaMissense
2575 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:236183841:T:A | W301R | 0.999 |
| 1:236183841:T:C | W301R | 0.999 |
| 1:236142884:T:A | W88R | 0.998 |
| 1:236142884:T:C | W88R | 0.998 |
| 1:236142965:T:A | W115R | 0.998 |
| 1:236142965:T:C | W115R | 0.998 |
| 1:236142998:T:C | F126L | 0.998 |
| 1:236143000:T:A | F126L | 0.998 |
| 1:236143000:T:G | F126L | 0.998 |
| 1:236178445:A:C | S166R | 0.998 |
| 1:236178447:C:A | S166R | 0.998 |
| 1:236178447:C:G | S166R | 0.998 |
| 1:236178454:T:C | F169L | 0.998 |
| 1:236178456:C:A | F169L | 0.998 |
| 1:236178456:C:G | F169L | 0.998 |
| 1:236178468:T:A | N173K | 0.998 |
| 1:236178468:T:G | N173K | 0.998 |
| 1:236180008:T:A | W273R | 0.998 |
| 1:236180008:T:C | W273R | 0.998 |
| 1:236183845:A:T | E302V | 0.998 |
| 1:236142984:C:A | P121H | 0.997 |
| 1:236178544:G:C | D199H | 0.997 |
| 1:236178553:T:C | F202L | 0.997 |
| 1:236178555:C:A | F202L | 0.997 |
| 1:236178555:C:G | F202L | 0.997 |
| 1:236179953:C:A | N254K | 0.997 |
| 1:236179953:C:G | N254K | 0.997 |
| 1:236180010:G:C | W273C | 0.997 |
| 1:236180010:G:T | W273C | 0.997 |
| 1:236183820:T:C | F294L | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000033289 (1:236196529 T>C), RS1000039683 (1:236188531 G>A,T), RS1000051492 (1:236157771 A>C), RS1000107230 (1:236157575 G>A), RS1000195671 (1:236181252 G>A), RS1000199317 (1:236170766 A>G), RS1000210833 (1:236168282 C>A), RS1000258518 (1:236162435 A>G), RS1000362456 (1:236167844 C>A), RS1000385901 (1:236194590 C>G), RS1000437957 (1:236169927 C>T), RS1000452881 (1:236196932 C>T), RS1000538559 (1:236161497 A>T), RS1000570321 (1:236165444 C>T), RS1000601480 (1:236165699 T>A)
Disease associations
OMIM: gene MIM:604658 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000883_6 | Response to antipsychotic treatment in schizophrenia (working memory) | 5.000000e-07 |
| GCST007094_191 | Diastolic blood pressure | 3.000000e-11 |
| GCST007098_34 | Diastolic blood pressure | 6.000000e-06 |
| GCST007099_202 | Systolic blood pressure | 5.000000e-07 |
| GCST008161_59 | Waist circumference adjusted for body mass index | 1.000000e-06 |
| GCST009391_753 | Metabolite levels | 3.000000e-06 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004335 | short-term memory |
| EFO:0006336 | diastolic blood pressure |
| EFO:0006335 | systolic blood pressure |
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0010390 | sphingomyelin 14:0 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
61 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 5 |
| Cyclosporine | affects expression, increases expression | 3 |
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Benzo(a)pyrene | affects methylation | 2 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 2 |
| Testosterone | affects cotreatment, increases expression | 2 |
| Tretinoin | increases expression | 2 |
| Aflatoxin B1 | affects methylation, decreases methylation | 2 |
| Particulate Matter | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | increases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| methylmercuric chloride | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases expression | 1 |
| quercitrin | increases expression | 1 |
| terbufos | decreases methylation | 1 |
| trichostatin A | increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| vanadyl sulfate | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | increases expression, affects cotreatment | 1 |
| ICG 001 | increases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E0E1 | Ubigene HeLa GPR137B KO | Cancer cell line | Female |
| CVCL_SQ44 | HAP1 GPR137B (-) 1 | Cancer cell line | Male |
| CVCL_SQ45 | HAP1 GPR137B (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.